Recombination in alphaherpesviruses was first described more than sixty years ago. Since then, different techniques have been used to detect recombination in natural (field) and experimental settings. Over the last ten years, next-generation sequencing (NGS) technologies and bioinformatic analyses have greatly increased the accuracy of recombination detection, particularly in field settings, thus contributing greatly to the study of natural alphaherpesvirus recombination in both human and veterinary medicine. Such studies have highlighted the important role that natural recombination plays in the evolution of many alphaherpesviruses. These studies have also shown that recombination can be a safety concern for attenuated alphaherpesvirus vaccines, particularly in veterinary medicine where such vaccines are used extensively, but also potentially in human medicine where attenuated varicella zoster virus vaccines are in use. This review focuses on the contributions that NGS and sequence analysis have made over the last ten years to our understanding of recombination in mammalian and avian alphaherpesviruses, with particular focus on attenuated live vaccine use.
Highlights:
-Natural (field) recombination in alphaherpesviruses is linked with live attenuated vaccine usage.
-Natural recombination drives evolution and pathogenicity of alphaherpesviruses.
-Advances in next-generation sequencing techniques have helped to provide accurate data in regards to natural (field) recombination.
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Introduction 50
Viruses belonging to the order Herpesvirales have a double stranded DNA genome and have been 51 isolated from a wide variety of host including mammals, birds, reptiles, fish and invertebrates 52 (Davison, 2010) . Three large subfamilies arose within the family Herpesviridae over 80 million 53 years ago. One of these, the subfamily Alphaherpesvirinae, includes avian and mammalian 54 alphaherpesvirus lineages (Davison, 2010; McGeoch et al., 1995) . The evolution of many viruses in 55 this subfamily has been attributed, in part, to the process of recombination. The contribution that 56 recombination makes to the evolution and diversity of alphaherpesviruses is of particular 57 importance as these viruses have a DNA polymerase with a highly efficient proof-reading activity 58 and exonuclease activity (Javier et al., 1986; Lee et al., 2012; Thiry et al., 2005) , resulting in low 59 point genetic mutation rates. In herpes simplex virus-1 (HSV-1) the mutation rate is as low as 0.026 60 to 0.0027 (Drake and Hwang, 2005) . 61
Recombination is the process in which new genetic material (offspring) is generated by shuffling 62 two different DNA sequences from viruses infecting the same host cell at the same time. High rates 63 of in vivo intra-species homologous recombination have been demonstrated after experimental co-64 inoculation of different strains of HSV-1 into mice (Kintner et al., 1995) , bovine herpesvirus 1 65 (BoHV-1) into calves (Schynts et al., 2003) , and pseudorabies virus (PRV) into sheep and pigs 66 (Christensen and Lomniczi, 1993; Henderson et al., 1990) . In vitro intra-species co-inoculation 67 experiments have demonstrated recombination in different alphaherpesviruses strains into cell 68 cultures, including HSV-1 (Kintner et al., 1995) , BoHV-1 (Muylkens et al., 2009 ), varicella zoster 69 virus (VZV) (Dohner et al., 1988) , feline herpesvirus 1 (FeHV-1) (Fujita et al., 1998) and PRV 70 (Henderson et al., 1990) . In vitro recombination has been detected at a lower rate than in in vivo 71 experiments, possibly due to the reduced number of viral replication cycles possible in cell cultures. 72
Therefore, factors that influences the number of viral replication cycles, such as latency/reactivation 73 and use of vaccines that replicate after vaccination, should be considered as factors that may 74 increase the likelihood of recombination. Recombination occurs most commonly between different 75 strains of the same virus species (intra-species recombination) but inter-species recombination is 76 also possible and has been detected in experimental studies between caprine herpesvirus- 1 and -2, 77 and also between BoHV-1 and bovine herpesvirus-5 (BoHV-5) (Meurens et al., 2004) . In field 78 samples inter-species recombination has been detected between equine herpesviruses 1 and 4 79 (EHV-1 and EHV-4, respectively) (Pagamjav et al., 2005) . 80
Many biological features of alphaherpesviruses, including their infection of epithelial surfaces, 81 rapid infectious cycle, establishment of latent infection with periodic reactivation and high 82 prevalence of infection in many host populations, create a favourable environment for co-infection 83 of host cells, and hence for recombination. The viral, host and cell conditions that influence the 84 likelihood of recombination in vivo and in vitro under laboratory conditions have been reviewed 85 previously (Thiry et al., 2005) . The molecular basis of alphaherpesvirus recombination has also 86 been recently reviewed and is hypothesized to be similar to that described for lambda 87 bacteriophages (Lo Piano et al., 2011; Weller and Sawitzke, 2014) . 88
Early studies of alphaherpesvirus recombination used strain virulence as a marker to detect 89 recombinants (Wildy, 1955) . Analysis of partial genome sequences were then used extensively to 90 study recombination in several alphaherpesviruses, using tools such as PCR followed by restriction 91 endonuclease cleavage fragment analysis of PCR products (PCR plus restriction fragment length 92 polymorphism [PCR-RFLP]), gene deletion mutants, PCR hydrolysis probe assays and 93 bioinformatic comparisons of partial genome sequences to detect recombination (Bowden et al., 94 2004; Christensen and Lomniczi, 1993; Dangler et al., 1993; Dohner et al., 1988; Glazenburg et al., 95 1994; Henderson et al., 1990; Javier et al., 1986; Kintner et al., 1995; Muylkens et al., 2009; 96 Norberg et al., 2004; Sakaoka et al., 1995; Sakaoka et al., 1994; Schynts et al., 2003; Umene and 97 Sakaoka, 1997 Zhao et al., 2015) . 108
This review aims to summarise and update our understanding of natural recombination in 109 alphaherpesviruses and the influence of natural recombination on viral evolution, focusing on the 110 contributions that full genome sequencing and sequence analysis have made to this field over the 111 last 10 years. This review covers natural recombination in human alphaherpesviruses, other 112 mammalian alphaherpesviruses and avian alphaherpesviruses. 113 114
Natural recombination in human alphaherpesviruses 115
Herpes simplex virus-1, -2 and VZV are important causes of human disease worldwide. Infection 116 with HSV-1 is commonly associated with ulcerated oral lesions and HSV-2 with genital lesions, 117 although both viruses can cause lesions at both anatomical sites (Lowhagen et al., 2002) . 118
Additionally, HSV-1 can cause keratitis and subsequent blindness, along with sporadic encephalitis 119 (Liesegang, 2001) . Infection with VZV causes varicella (chickenpox) and herpes zoster (shingles) 120 (Zerboni et al., 2014) . Evidence of natural recombination has been available since 2004 for HSV-1, 121 7 than the parental strains (Brandt and Grau, 1990; Kintner et al., 1995) . This potential for 128 recombination to result in increased virulence highlighted the importance of studying HSV- clades (Kolb et al., 2011) . In regard to recombination, Kolb et al., (2011) showed that some field 144 strains (TFT401 and CJ970) were unstable in their phylogenetic classification using the whole 145 genome sequence and identified cross over points using similarity plots in the UL1, UL11, UL43, 146 UL49A, US4 and US7 genes. Additionally, they found that some nucleotide sequences that code for 147 selected proteins resulted in variable phylogenetic groupings depending on the parameters used to 148 build the phylogenetic trees. They concluded that recombination was likely and that each viral 149 genome is a unique mosaic (Kolb et al., 2011) . (US), Europe and Japan. Both these studies confirmed that recombination in HSV-1 is widespread, 158 frequent, historical and ongoing (Kolb et al., 2013; Szpara et al., 2014) . In addition, these two 159 studies found that the HSV-1 strains clustered into six groups, rather than the three groups 160 described previously. The clustering correlated with the geographic origin of the isolates, 161
highlighting the need to include isolates from different regions in order to comprehensively 162 examine phylogeny and recombination (Kolb et al., 2013; Szpara et al., 2014) . 163
The high levels of HSV-1 recombination detected in these studies have been hypothesised to be due 164 to the co-existence of many different HSV-1 strains within the same geographical region (Norberg 165 et al., 2004; Schmidt-Chanasit et al., 2009 ) and to the high number of HSV-1 replication cycles that 166 which may arise from more frequent HSV-1 reactivation from latency, compared to HSV-2 or VZV 167 (Kaufman et al., 2005; Wang et al., 2010) . This suggests that the latency and reactivation 168 characteristics of alphaherpesviruses are also factors that can influence recombination, with viruses 169 that establish and re-activate from latency more frequently having a higher likelihood of 170 recombination. 171 172
Herpes simplex virus-2 173
The first study to detect recombination in HSV-2 using bioinformatics analyses of partial DNA 174 sequences from clinical isolates was published by Norberg et al., (2007) . Approximately 3.5% of 175 the genome of 47 clinical isolates of HSV-2 from Norway, Sweden, and Tanzania was examined 176
and it was found that HSV-2 was clustered into 2 genogroups, rather than the 3 groups seen in 177 HSV-1 isolates using similar techniques. Isolates from Norway and Sweden were clustered into 9 compared to HSV-1, was directly related to recombination (Norberg et al., 2007) . Importantly, 180 however, these conclusions were based on the analysis of only a limited number of samples, and of 181 partial genome sequences. Only three genes within the unique short (US) region of the HSV-2 182 genome were examined (US4, US7 and US8) (Norberg et al., 2007) . Studies on HSV-1 had 183 detected variation in diversity across the whole genome, which can influence recombination 184 analysis (Szpara et al., 2014) . Thus, in order to comprehensively examine recombination in HSV-2, 185 and also compare recombination between HSV-1 and HSV-2, an analysis of HSV-2 recombination 186 analyses at the whole genome level was required. 187
Prior to 2014 there were only two full genome sequences for HSV-2, one published in 1998 (Dolan 188 et al., 1998) , and another one in 2014 (Colgrove et al., 2014) . Kolb et al., (2015) determined the 189 complete genome sequences of an additional six HSV-2 clinical isolates. Bootscan analysis of the 190 eight complete genome sequences demonstrated that the HSV-2 genomes were mosaics, suggesting 191 frequent recombination randomly along the genome . In a separate study, 34 near 192 complete genome sequences were determined for HSV-2 isolates from Africa, USA and Japan. 193
Bootscan and phylogenetic analyses of these sequences suggested that HSV-2 had five major 194 crossover points and that recombination in HSV-2 did not occur as frequently as in HSV-1 195 including Japan, Korea, the US, Canada, Australia, Germany, Costa Rica, Uruguay, and Qatar 214 (Norberg et al., 2015) . As VZV recombination has been observed in cell culture (Dohner et al., 215 1988 ) there is potential for natural recombination, including between vaccine and wild type viruses, 216 to occur (Quinlivan et al., 2009 ). This has been the focus of a number of studies examining VZV 217 recombination. VZV recombination has been investigated using partial and full genome sequence 218 analyses to identify viral groups (clades), and to detect recombination events (Norberg et These studies showed that recombination occurs among VZV isolates and also enabled the 227 classification of VZV isolates into different phylogenetic groups. Loparev et al., (2004) were able 228 to classify 326 VZV isolates from the six continents into the European (E), Japanese (J) and the sequence of 16 isolates. Specifically, the M group was identified as carrying SNP patterns of both 232 the E and J group, and it was hypothesised that M strains resulted from recombination after mixed 233 infection (Loparev et al., 2004) . A separate study classified isolates into four major clades, with 234 clade A containing European/North American (Dumas) isolates, clade B Japanese (vaccine-Oka) 235
isolates, clade C Asian-like isolates sharing some European/North American features, and clade D 236
containing European/North American-like isolates sharing some features of the Asian strains 237 (Wagenaar et al., 2003) . These classifications provided the first insight into natural recombination 238 in VZV, but more detailed understanding was later achieved by full genome sequence analyses. 239
Complete genome sequence analyses were first used to detect natural VZV recombination in 2006 240 (Norberg et al., 2006; Peters et al., 2006) . The two studies reporting these findings had different 241 foundations but both reached similar conclusions about recombination. One investigated 242 recombination within the clades C and D (Asian-like and European/North American-like, 243 respectively) at the full genome level (Peters et al., 2006) . This study determined the full genome 244 sequences of 11 VZV isolates that were considered representative for Canada and the USA, and 245 compared them to seven other sequences that were publicly available (Peters et al., 2006) . They 246 detected evidence of recombination within a Canadian isolate (VZV-8) within clade C that 247 contained mixtures of genetic characteristics from clade A (Dumas strain from Europe/North 248 America) and clade B (pOka strain from Japan). It was hypothesised that this isolate arose as a 249 result of a recombination event between the vaccine strain vOka from Japan and VZV field strains 250 from Canada, as the vaccine strain is used in Canada (Peters et al., 2006) . However, as the vaccines 251 contains mixtures of distinct genetic subtypes (Quinlivan et al., 2005; Vassilev, 2005 ) and the 252 sequences available at the time in 2006 did not include all the strains within the vaccine, it was not 253 possible to reach this conclusion definitely (Peters et al., 2006) . 254
The second study (Norberg et al., 2006) determined the full genome sequences of two VZV strains 255 (DR and 123) that were classified previously into group M (mosaic) by Loparev et al., (2004) and 256 thus contained genetic features from groups E (European) and J (Japanese). At the whole genome level, the DR and 123 strains were shown to be well separated from each other and from groups E 258 and J. Thus, group M was further divided into M1, represented by the 123 strain, and M2, 259
represented by the DR strain. Bootscan analysis suggested that that the DR and 123 strains contain 260 putative recombination dependent sites. Specifically, some genomic regions clustered with pOka, 261 while other regions of the VZV genome clustered with the European strains (Norberg et al., 2006) . 262
Subsequent phylogenetic network analysis revealed that the SVETA strain, which is a Russian 263 isolate and was thought to belong to clade 1 (European clade), had been involved in an intra-clade 264 recombination event (Norberg et al., 2011) , and significant intra-clade recombination events were 265 found among other VZV isolates (Zell et al., 2012) . 266
After intra-clade recombination was observed, it was hypothesised that an increase in the number of 267 full genome sequences available for analysis would reveal a greater number of recombinants. 268
Additionally, it was hypothesised that human migration, along with widespread distribution of the 269 attenuated VZV vaccine strains (Takahashi et al., 1974) , may contribute to an apparent 270 disappearance of VZV clades as recombination events would result in isolates becoming genomic 271 mosaics similar to HSV-1 (Norberg et al., 2004; Sauerbrei and Wutzler, 2007; Sauerbrei et al., 272 2008) . However, recent studies that have included several isolates from different continents have 273
shown that the only clade to consistently display a relatively high level of recombination is the 274 clade that contains the pOka and vOka vaccine strains (Norberg et al., 2015) . Detection of 275 recombination in the other clades appears to be dependent on the analytical method used to detect 276 evidence of recombination (Norberg et al., 2015) . (Luo et al., 2014) . The first study using 379 whole genome sequence analysis to detect natural recombination in PRV has been published 380 recently (Ye et al., 2016) . This study has shown that a historical Chinese PRV strain (SC) isolated 381 during the 1980s is a recombinant derived from an endemic Chinese PRV strain and a Bartha-like 382 strain (Ye et al., 2016) . Experimental studies have shown that Bartha-K61 can induce protection 383 against the SC strain but not against the new variants (Luo et al., 2014) . The SC strain has genomic 384 regions similar to the Bartha strain, so it has been hypothesised that these similar regions may 385 account for the capacity of the Bartha strain vaccine to protect against the SC strain, but not the new 386 variants, and that this difference in protective immunity may have permitted the new variants to 387 circulate in pig herds and cause disease (Ye et al., 2016 ) 388 389
Feline herpesvirus-1 390
Recombination between FeHV-1 isolates has been demonstrated in vitro (Fujita et al., 1998) , but 391 only one study has investigated natural recombination in FeHV-1 using NGS (Vaz et al., 2016b) . 392
Feline herpesvirus-1 is the aetiological agent of feline viral rhinotracheitis and also a common cause 393 of ocular lesions in cats (Maes, 2012) . Inactivated and attenuated vaccines are used widely, but do 394 not prevent infection (Jas et al., 2009) . Previous studies using techniques such as restriction 395 endonuclease digestion of the genome, and analysis of partial genomic sequences suggested low 396 levels of diversity among several isolates (Maeda et al., 1995) . Comparison of the whole genomes 397 of 24 historical and contemporary FHV-1 clinical isolates and 2 US-origin commercial vaccine 398 viruses in use worldwide confirmed that FeHV-1 isolates are highly homogeneous and has revealed 399 no evidence of recombination (Vaz et al., 2016b) . This is the first alphaherpesvirus in which 400 recombination has been shown to occur under experimental (in vitro) conditions, but not under 401 natural in vivo conditions. Low rates of FeHV-1 recombination in vivo have been hypothesised 402 previously, as FeHV-1 is more homogeneous than other alphaherpesviruses (Fujita et al., 1998) and genes with unusually high degrees of synonymous divergence were identified, suggesting the 418 past homologous recombination events (Hughes and Rivailler, 2007) . This study identified three 419 clusters of orthologous genes based on their patterns of synonymous substitutions in order to use 420 them for further recombination analysis (Hughes and Rivailler, 2007) . Eight loci within the four 421
GaHV-2 genomic sequences were highly homogenous, suggesting homologous recombination 422 between the vaccine strain CVI988, the highly virulent field strain (Md5) and the virulent Md11 423 strain. Additionally, phylogenetic analyses of the GA, Md5 and Md11 strains found that the virulent 424 GA strain generally clustered separately from the highly virulent Md5 and Md11 strains, but further 425 analyses of the UL 49.5 and RL ORF12 genes detected a high level of homogeneity between the 426 GA, Md5 and Md11 strains, suggesting that recombination had resulted in the transfer of virulence 427 factors between these strains. The approach used in this study to detect recombination differed from 428 those used for other alphaherpesviruses, such as HSV-1, HSV2, VZV, EHV-1, EHV-4, FeHV- the method used was extrapolated from those used to detect sites of homologous recombination 433 within bacterial genomes. This approach examines the synonymous substitution distribution 434 patterns among orthologous protein coding genes, with higher synonymous substitutions per site Analyses of GaHV-2 genome sequences for evidence of recombination, using methods similar to 437 those used for other alphaherpesviruses, would help to further explore these findings. To this end, 438 we examined the 15 GaHV-2 genome sequences publicly available at NCBI database (Table 4) for 439 recombination using the SplitsTree 4 software and RDP4 software packages, as detailed previously 440 (Vaz et al., 2016a; Vaz et al., 2016b) . These analyses revealed evidence of recombination within 441 the unique short region of the GaHV-2 genome using the SplitsTree 4 software ( Figure 1C) (Huson 442 and Bryant, 2006) and in all regions of the GaHV-2 genome using RDP4 software (Table 5) . 443
Together these results provide evidence of recombination in GaHV-2 but further study into the 444 importance of recombination for GaHV-2 evolution and genome diversification is warranted, 445
including examination of a larger number of GaHV-2 field isolates. 446 447
Infectious laryngotracheitis virus 448
Natural recombination in ILTV was first described by our laboratory in the context of attenuated 449 vaccine use in Australia (Lee et al., 2012) . This study provided clear evidence of natural 450 recombination in ILTV, and also demonstrated safety concerns associated with the use of live 451 attenuated alphaherpesvirus vaccines, a risk that had previously only been hypothesised. Prior to the 452 detection of ILTV recombinants, two new genotypes of ILTV were shown to be dominant in 453
Australia. These new genotypes, named as class 8 and 9 ILTV, had similar PCR-RFLP patterns, and 454 clustered close to the Class 7 genotype (which includes the Serva vaccine strain) (Blacker et al., 455 2011 ). These studies, together with similar findings around the world led to the hypothesis that live 456 attenuated ILTV vaccines could displace wild type strains and cause outbreaks of disease (Garcia 457 and Riblet, 2001; Graham et al., 2000) . However, the subsequent whole genome sequencing studies 458 showed that natural recombination between the vaccine strains in use in Australia was responsible 459 for the rise of the virulent Class 8 and 9 ILTV strains (Lee et al., 2012) . These conclusions were 460 supported by the use of the BootScan algorithm within the SimPlot program, which revealed the origin SA2 and A20 vaccine strains (Lee et al., 2012) . These findings echoed earlier studies that 463 showed that recombination between two attenuated HSV-1 strains could generate more virulent 464 strains in a mouse model of infection (Javier et al., 1986) . 465
In order to further investigate natural recombination in ILTV, full genome sequence data of other 466
Australian ILTV isolates, along with full genome sequences of isolates from the US, were 467 compared. The analyses revealed extensive recombination networks between ILTV isolates from 468 both Australia and the US, and also uncovered new phylogenetic relationships between isolates 469 (Lee et al., 2013) . Recombination involving vaccine strains has been described in VZV, MDV (GaHV-2), ILTV 493 (GaHV-1) and PRV, but the recombination events in these virus species have differed in their 494 nature and consequences. In ILTV, two vaccine strains recombined to produce a virulent 495 recombinant that became a dominant field strain (Lee et al., 2012) . In PRV, recombination occurred 496 between a vaccine strain and a field strain, potentially contributing to vaccine-induced selection and 497 protection of another, genetically less similar, field strain (Ye et al., 2016) . These studies provide 498 examples of how vaccines and recombination can have an impact on viral evolution and alter the 499 selection pressure on a viral population to result in greater dissemination of more pathogenic 500 viruses. As live attenuated vaccines are favoured in veterinary medicine, their impact on viral 501 ecology and evolution should be evaluated and monitored at a population level. Targeted 502 monitoring of recombination after the introduction of new vaccine strains would be helpful for 503 detecting the rise of new, potentially more virulent strains. Consideration of recombination risks in 504 the assessment of vaccine safety during the process of registration could also be advantageous. 505
Currently, natural recombination has not been assessed in BoHV-1 or herpesvirus of turkeys (HVT) 506 but live vaccines using these viruses are in widespread use in the cattle and poultry industries, 507 respectively, with the latter being used as vaccine vector to express exogenous proteins from other 508 avian pathogens (Kapczynski et al., 2015; Li et al., 2011; Roh et al., 2016) . Examining natural 509 recombination in these two viruses should be included in future research in order to determine 510 potential risks to animal health. 511
Over the last 10 years the development of new more sophisticated and accessible NGS techniques, 512 along with advances in computational and statistical analysis, has dramatically enhanced the study 513 of natural recombination in alphaherpesviruses. Detection of recombination using more than one 514 approach is recommended and can now be achieved using a number of different bioinformatic 515 analysis software. Commonly used programs include the Recombination Detection Program (RDP), 516 SplitsTree software, the Genetic Algorithm Recombination Detection (GARD) program and 517
SimPlot software. The latest version of RDP (RDP4) was made available in 2015 (Martin et al., 518 2015) and includes nine non-parametric recombination detection methods (Martin et al., 2010) . 519 SplitTree software uses phylogenetic and reticulate networks, in addition to the pairwise homology 520 test (PHI test), to search for the presence of recombination in a given set of aligned sequences 521 (Huson and Bryant, 2006) . The GARD program searches for evidence of segment-specific 522 phylogenies. GARD is a likelihood-based model selection procedure that searches multiple 523 sequence alignments for evidence of recombination breakpoints and identifies putative recombinant 524 sequences (Kosakovsky Pond et al., 2006) . SimPlot allows the analysis of sequence alignments, and 525 searches for breakpoint locations. This program ignores sites containing gaps, and produces a 526 similarity plot identifying the sequence position and the similarity value at each point in the 527 sequence (Lole et al., 1999) . The application of more than one method is desirable to increase the 528 robustness and consistency of the results, since a true recombination event should be independent of 529 the method of analysis. 530
Sequence quality is also crucial to the accurate detection of recombination events in full genome 531 sequences. Consideration of a measurement of quality such as Phred score and avoiding low 532 sequence quality and parental sequence uncertainty is strongly recommended, since detection of 533 breakpoint locations, and thus recombination, may be unreliable in low quality sequences (Posada, 534 2002; Posada and Crandall, 2001 ). Inclusion of detailed information describing the methods used in 535 recombination analyses is also desirable, specifically in regard to the preparation of the sequences 536 that are used for recombination analysis such as the trimming of short sequence repeats (SSR), 537 tandem repeat regions (TRR), and terminal repeated regions (TR). It is recommended to remove 538 these sequences from analyses as they can bias recombination analysis (Dutch et al., 1995; Lee et 539 al., 2015; Newman et al., 2015; Vaz et al., 2016a) . Finally, studies focused on natural herpesvirus 540 recombination should aim to include high quality information about the samples and virus isolates 541 so that the results from recombination analyses can be considered in the context of relevant clinical 542 and epidemiological information. Pairing recombination analyses with an understanding of the 543 epidemiology and pathogenesis of the viruses offers the greatest potential to understand the 544 importance of recombination and the role that it may be playing in virus evolution. Indeed, some of 545 the most important findings relating to recombination and the involvement of attenuated vaccines 546 have come from studies that have integrated recombination, epidemiological and viral pathogenesis. 547
Maintaining such a focus in future studies will be important for achieving a comprehensive 548 understanding of alphaherpesvirus recombination. 549
This review has highlighted the significance of natural recombination in many viruses of 550 importance to human and veterinary medicine and has demonstrated the power of using full genome 551 sequencing and sequence analysis to examine natural herpesvirus recombination. It is likely that 552 continued advances in technology and methodologies, further reductions in the cost of NGS 553 techniques and improved bioinformatics tools to assess recombination will enable further 554 developments in the field of recombination, in particular by facilitating the affordable examination 555 of increasing numbers of clinical isolates from diverse widespread geographical regions. 556 the rate of evolution in sequence substitution per site. P values for the PHI test for detecting 949 recombination, as implemented in SplitsTree4, are shown and were highly significant for the 950 complete genome and for the unique short region. D) Unique long region. Details about the 951 nucleotide sequences used in these analyses are shown in Table 4 . 952 Table 1 . Timeline and summary of key studies examining natural recombination in human alphaherpesviruses.
Year
Summary of study findings Reference
Herpes simplex virus 1 (HSV-1)
2004 Evidence of recombination in partial genome sequences (4% of the genome) from 14 clinical samples from UK compared with samples from Seoul and South Korea.
